Sentinel Lymph Node Biopsy
"Sentinel Lymph Node Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The SENTINEL LYMPH NODE is the first lymph node to receive drainage from a neoplasm.
| Descriptor ID |
D021701
|
| MeSH Number(s) |
E01.370.225.500.384.100.580 E01.370.225.998.054.580 E01.370.388.100.580 E04.074.580 E04.446.819 E05.200.500.384.100.580 E05.200.998.054.580 E05.242.384.100.580
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node Biopsy".
This graph shows the total number of publications written about "Sentinel Lymph Node Biopsy" by people in this website by year, and whether "Sentinel Lymph Node Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 2 | 3 |
| 2012 | 4 | 1 | 5 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 3 | 5 |
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 5 | 7 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 3 | 3 | 6 |
| 2025 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sentinel Lymph Node Biopsy" by people in Profiles.
-
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy. Br J Surg. 2025 Mar 28; 112(4).
-
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3203-3211.
-
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291.
-
Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3189-3197.
-
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study. Int J Gynecol Cancer. 2024 Feb; 34(2):179-187.
-
Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Ann Surg Oncol. 2025 Mar; 32(3):1429-1442.
-
Incidental detection of non-melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series. J Cutan Pathol. 2024 Dec; 51(12):1000-1007.
-
Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e438776.
-
Influence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes. J Drugs Dermatol. 2024 May 01; 23(5):306-310.
-
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study. Int J Gynecol Cancer. 2024 02 05; 34(2):179-187.